Niklas Schuelert

Birkendorfer Str. 65
Biberach An Der Riss, BW 88397, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Discovery of VU6024578/BI02982816: An mGlu1 Positive Allosteric Modulator with Efficacy in Preclinical Antipsychotic and Cognition Models.

Discovery of VU6024578/BI02982816: An mGlu1 Positive Allosteric Modulator with Efficacy in Preclinical Antipsychotic and Cognition Models.

Journal: Journal of medicinal chemistry

Published: December 12, 2024

Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction.

Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction.

Journal: Neuropharmacology

Published: February 15, 2024

Reply to the Letter to the Editor regarding; Not mismatch negativity modulation of sensory N1 is measured.

Reply to the Letter to the Editor regarding; Not mismatch negativity modulation of sensory N1 is measured.

Journal: Neuroscience

Published: November 11, 2022

Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice.

Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice.

Journal: Translational psychiatry

Published: April 14, 2022

Increasing the Excitatory Drive Rescues Excitatory/Inhibitory Imbalance and Mismatch Negativity Deficit Caused by Parvalbumin Specific GluA1 Deletion.

Increasing the Excitatory Drive Rescues Excitatory/Inhibitory Imbalance and Mismatch Negativity Deficit Caused by Parvalbumin Specific GluA1 Deletion.

Journal: Neuroscience

Published: January 28, 2022

Effects of the Glycine Transporter-1 Inhibitor Iclepertin (BI 425809) on Sensory Processing, Neural Network Function, and Cognition in Animal Models Related to Schizophrenia.

Effects of the Glycine Transporter-1 Inhibitor Iclepertin (BI 425809) on Sensory Processing, Neural Network Function, and Cognition in Animal Models Related to Schizophrenia.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 22, 2021

Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809).

Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809).

Journal: Translational psychiatry

Published: December 07, 2021

Suppression of Parvalbumin Interneuron Activity in the Prefrontal Cortex Recapitulates Features of Impaired Excitatory/Inhibitory Balance and Sensory Processing in Schizophrenia.

Suppression of Parvalbumin Interneuron Activity in the Prefrontal Cortex Recapitulates Features of Impaired Excitatory/Inhibitory Balance and Sensory Processing in Schizophrenia.

Journal: Schizophrenia bulletin

Published: January 07, 2020

Differential effects of traxoprodil and S-ketamine on quantitative EEG and auditory event-related potentials as translational biomarkers in preclinical trials in rats and mice.

Differential effects of traxoprodil and S-ketamine on quantitative EEG and auditory event-related potentials as translational biomarkers in preclinical trials in rats and mice.

Journal: Neuropharmacology

Published: October 10, 2019

A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology.

A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology.

Journal: Physiological reports

Published: February 27, 2018

Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance.

Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance.

Journal: British journal of pharmacology

Published: December 11, 2017

Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain.

Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain.

Journal: Osteoarthritis and cartilage

Published: March 04, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026